Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 679 | 606 | 594 | 4,383 | 224 |
| Cost of Goods | 645 | 463 | 420 | 1,491 | 76 |
| Gross Profit | 34 | 143 | 174 | 2,892 | 148 |
| Operating Expenses | 2,426 | 2,367 | 2,121 | 2,623 | 1,754 |
| Operating Income | -1,747 | -1,761 | -1,527 | 760 | -1,530 |
| Interest Expense | 1,391 | 6 | 582 | 1,809 | 6 |
| Other Income | -39 | 519 | -131 | -238 | 215 |
| Pre-tax Income | -3,177 | -1,248 | -2,240 | -1,287 | -1,321 |
| Net Income Continuous | -3,177 | -1,248 | -2,240 | -1,287 | -1,321 |
| Net Income | $-3,177 | $-1,248 | $-2,240 | $-1,287 | $-1,321 |
| EPS Basic Total Ops | -0.68 | -0.27 | -0.48 | -0.28 | -0.29 |
| EPS Basic Continuous Ops | -0.68 | -0.27 | -0.48 | -0.17 | -0.29 |
| EPS Diluted Total Ops | -0.68 | -0.27 | -0.48 | -0.28 | -0.29 |
| EPS Diluted Continuous Ops | -0.68 | -0.27 | -0.48 | -0.17 | -0.29 |
| EBITDA(a) | $-1,605 | $-1,630 | $-1,430 | $821 | $-1,404 |